hCD38(2)
Nomenclature
C57BL/6Smoc-Cd38tm2(CD38)Smoc
Cat. NO.
NM-HU-190059
Strain State
Repository Live
Gene Summary
Gene Symbol
CD38
Model Description
Validation Data
Fig1. hCD38 is highly expressed on both B cells and T cells in human PBMC.
Fig2. m/hCD38 is highly expressed on blood and spleen-derived B cells in hCD38 knockin mice.
Fig3. m/hCD38 can be detected on blood-derived T cells in hCD38 knockin mice.
Fig4. m/hCD38 can be detected on spleen-derived T cells in hCD38 knockin mice.
Fig5. In vivo anti-tumor effect of Daratumumab in hCD38 knockin mice. Homozygous humanized CD38 mice were inoculated with E.G7-OVA T lymphoma cells. The results showed: Daratumumab , a drug targeting human CD38, showed a very significant anti-tumor effect , demonstrating that the humanized CD38 mouse model is a good in vivo model for validating the efficacy of antibodies targeting human CD38.（ In cooperation with Crownbio）
Fig6. Binding assay of Daratumumab to hCD38-derived B cells.（ In cooperation with Crownbio）
Fig7. Binding assay of Daratumumab to hCD38-derived T cells.（ In cooperation with Crownbio）
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreSMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn more
